Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000891839-19-000042
Filing Date
2019-03-18
Accepted
2019-03-18 17:59:18
Documents
1
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 12726
  Complete submission text file 0000891839-19-000042.txt   14537
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
FRIEDBERG ALBERT (Reporting) CIK: 0001268239 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38624 | Film No.: 19689572

Mailing Address 44 WOODLAND ROAD PITTSFORD NY 14534
Business Address 44 WOODLAND ROAD PITTSFORD NY 14534 585-271-2827
Vaccinex (Rochester), L.L.C. (Reporting) CIK: 0001747866 (see all company filings)

State of Incorp.: GA | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-38624 | Film No.: 19689573